EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:176897 |
| ChEBI Name | GSK-5498A |
| Stars | |
| Definition | A member of the class of pyrazoles that is 1H-pyrazole substituted by 2-fluoro-6-(trifluoromethyl)benzyl and (2,6-difluorobenzoyl)amino groups at positions 1 and 3, respectively. It is a inhibitor of Ca2+ release-activated Ca2+ (CRAC) channel and inhibits the release of mast cell mediators and T-cell cytokines in human and rat preparations. |
| Last Modified | 23 July 2021 |
| Submitter | Ceri |
| Downloads |
| Formula | C18H11F6N3O |
| Net Charge | 0 |
| Average Mass | 399.294 |
| Monoisotopic Mass | 399.08063 |
| SMILES | O=C(Nc1ccn(Cc2c(F)cccc2C(F)(F)F)n1)c1c(F)cccc1F |
| InChI | InChI=1S/C18H11F6N3O/c19-12-4-1-3-11(18(22,23)24)10(12)9-27-8-7-15(26-27)25-17(28)16-13(20)5-2-6-14(16)21/h1-8H,9H2,(H,25,26,28) |
| InChIKey | AUBGZAJDHUHMAE-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | calcium channel blocker One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| GSK-5498A (CHEBI:176897) has role calcium channel blocker (CHEBI:38215) |
| GSK-5498A (CHEBI:176897) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| GSK-5498A (CHEBI:176897) is a difluorobenzene (CHEBI:38582) |
| GSK-5498A (CHEBI:176897) is a pyrazoles (CHEBI:26410) |
| GSK-5498A (CHEBI:176897) is a secondary carboxamide (CHEBI:140325) |
| IUPAC Name |
|---|
| 2,6-difluoro-N-{1-[2-fluoro-6-(trifluoromethyl)benzyl]-1H-pyrazol-3-yl}benzamide |
| Synonyms | Source |
|---|---|
| 2,6-difluoro-N-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-3-yl)benzamide | IUPAC |
| GSK5498A | ChEBI |
| GSK 5498A | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:1253186-49-0 | ChEBI |
| Citations |
|---|